ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX
Delisted
ORTX was delisted on the 23rd of January, 2024.
47 hedge funds and large institutions have $16.3M invested in Orchard Therapeutics plc American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
47
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$234K | |
| 2 | +$38.5K | |
| 3 | +$24.1K | |
| 4 |
Jane Street
New York
|
+$11K |
| 5 |
Goldman Sachs
New York
|
+$7.5K |
Top Sellers
| 1 | -$1.41M | |
| 2 | -$356K | |
| 3 | -$257K | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$216K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$25K |